Healthtech Startups
17,195 companies tagged Healthtech, with their investors and founders.
0 investors
Actinium is developing targeted radiotherapy treatments using Actinium-225 and related isotopes for oncology indications including prostate cancer, non-small cell lung cancer, breast cancer, and acute myeloid leukemia. The company's lead candidates include ATNM-400 for solid tumors and Actimab-A for blood malignancies.
0 investors
ActivArmor makes custom-fit, 3D printed waterproof casts and splints that let patients stay active while healing from fractures and injuries. The technology is offered to medical providers to use at their practices as an alternative to traditional casts.
0 investors
0 investors
0 investors
BoneScore makes the OsteoProbe, a handheld, radiation-free medical device that measures bone tissue strength by delivering a controlled impact and producing a Bone Material Strength Index (BMSi). Spun out of UC Santa Barbara and FDA-cleared, it is used in clinical settings to assess fracture risk in patients, including for conditions such as osteoporosis, diabetes, and kidney disease.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Acuitive Technologies is an orthopedic medical device company developing products using citrate-based biodegradable biomaterials for regenerative applications, including foot and ankle surgery. Its team consists of veterans of the orthopedic industry drawn from companies such as J&J, Zimmer, Stryker, and MAKO.
0 investors
0 investors
0 investors
0 investors
Acurx Pharmaceuticals is a clinical-stage biopharmaceutical company developing a new class of antibiotics targeting bacterial infections classified as priority pathogens by the WHO, CDC, and FDA. It is a publicly held company focused on antibiotic drug development.
0 investors
AMM operates higher-acuity urgent care facilities that deliver emergency-level acute care in community settings, reducing unnecessary emergency department visits while improving patient outcomes and experience. The company partners with healthcare systems to develop and operate advanced diagnostic and treatment centers across New Jersey.
0 investors
0 investors
0 investors
Adapt Biotechnologies develops the BRiTE platform, a bispecific antibody technology designed to treat brain tumors and intracerebral malignancies by activating T cells to target and destroy glioma cells. The platform combines manipulated T cells with bispecific antibodies to deliver targeted therapy to brain tissue.
0 investors
0 investors
0 investors
0 investors
0 investors